LC-QTOF-MS Identification of Major Urinary Cyclopropylfentanyl Metabolites Using Synthesized Standards
العنوان: | LC-QTOF-MS Identification of Major Urinary Cyclopropylfentanyl Metabolites Using Synthesized Standards |
---|---|
المؤلفون: | Henrik Gréen, Robert Kronstrand, Anna Åstrand, Shimpei Watanabe, Peter Konradsson, Johan Dahlén, Svante Vikingsson, Xiongyu Wu, Jakob Wallgren, Ariane Wohlfarth, Tobias Rautio |
المصدر: | Journal of Analytical Toxicology |
بيانات النشر: | Linköpings universitet, Avdelningen för läkemedelsforskning, 2019. |
سنة النشر: | 2019 |
مصطلحات موضوعية: | Health, Toxicology and Mutagenesis, Urinary system, Metabolite, Urine, Pharmacology and Toxicology, Toxicology, Mass spectrometry, 01 natural sciences, Mass Spectrometry, Analytical Chemistry, Lc qtof ms, Forensic Toxicology, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Enzymatic hydrolysis, Humans, Environmental Chemistry, 030216 legal & forensic medicine, Chemical Health and Safety, Chromatography, Special Issue, Chemistry, 010401 analytical chemistry, Metabolism, Reference Standards, Farmakologi och toxikologi, Metabolic Detoxication, Phase II, 0104 chemical sciences, Quinone, Analgesics, Opioid, Fentanyl, Substance Abuse Detection, Hepatocytes, Metabolic Detoxication, Phase I, Biomarkers, Chromatography, Liquid |
الوصف: | Cyclopropylfentanyl is a fentanyl analog implicated in 78 deaths in Europe and over 100 deaths in the United States, but toxicological information including metabolism data about this drug is scarce. The aim of this study was to provide the exact structure of abundant and unique metabolites of cyclopropylfentanyl along with synthesis routes. In this study, metabolites were identified in 13 post-mortem urine samples using liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). Samples were analyzed with and without enzymatic hydrolysis, and seven potential metabolites were synthesized in-house to provide the identity of major metabolites. Cyclopropylfentanyl was detected in all samples, and the most abundant metabolite was norcyclopropylfentanyl (M1) that was detected in 12 out of 13 samples. Reference materials were synthesized (synthesis routes provided) to identify the exact structure of the major metabolites 4-hydroxyphenethyl cyclopropylfentanyl (M8), 3,4-dihydroxyphenethyl cyclopropylfentanyl (M5) and 4-hydroxy-3-methoxyphenethyl cyclopropylfentanyl (M9). These metabolites are suitable urinary markers of cyclopropylfentanyl intake as they are unique and detected in a majority of hydrolyzed urine samples. Minor metabolites included two quinone metabolites (M6 and M7), not previously reported for fentanyl analogs. Interestingly, with the exception of norcyclopropylfentanyl (M1), the metabolites appeared to be between 40% and 90% conjugated in urine. In total, 11 metabolites of cyclopropylfentanyl were identified, including most metabolites previously reported after hepatocyte incubation. |
وصف الملف: | application/pdf |
اللغة: | English |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0298d28690a6bb961bbb0c4b9e34d186 http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-163109 |
Rights: | OPEN |
رقم الانضمام: | edsair.doi.dedup.....0298d28690a6bb961bbb0c4b9e34d186 |
قاعدة البيانات: | OpenAIRE |
ResultId |
1 |
---|---|
Header |
edsair OpenAIRE edsair.doi.dedup.....0298d28690a6bb961bbb0c4b9e34d186 820 3 unknown 819.664306640625 |
PLink |
https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....0298d28690a6bb961bbb0c4b9e34d186&custid=s6537998&authtype=sso |
FullText |
Array
(
[Availability] => 0
)
Array ( [0] => Array ( [Url] => https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0298d28690a6bb961bbb0c4b9e34d186# [Name] => EDS - OpenAIRE [Category] => fullText [Text] => View record in OpenAIRE [MouseOverText] => View record in OpenAIRE ) ) |
Items |
Array
(
[Name] => Title
[Label] => Title
[Group] => Ti
[Data] => LC-QTOF-MS Identification of Major Urinary Cyclopropylfentanyl Metabolites Using Synthesized Standards
)
Array ( [Name] => Author [Label] => Authors [Group] => Au [Data] => <searchLink fieldCode="AR" term="%22Henrik+Gréen%22">Henrik Gréen</searchLink><br /><searchLink fieldCode="AR" term="%22Robert+Kronstrand%22">Robert Kronstrand</searchLink><br /><searchLink fieldCode="AR" term="%22Anna+Åstrand%22">Anna Åstrand</searchLink><br /><searchLink fieldCode="AR" term="%22Shimpei+Watanabe%22">Shimpei Watanabe</searchLink><br /><searchLink fieldCode="AR" term="%22Peter+Konradsson%22">Peter Konradsson</searchLink><br /><searchLink fieldCode="AR" term="%22Johan+Dahlén%22">Johan Dahlén</searchLink><br /><searchLink fieldCode="AR" term="%22Svante+Vikingsson%22">Svante Vikingsson</searchLink><br /><searchLink fieldCode="AR" term="%22Xiongyu+Wu%22">Xiongyu Wu</searchLink><br /><searchLink fieldCode="AR" term="%22Jakob+Wallgren%22">Jakob Wallgren</searchLink><br /><searchLink fieldCode="AR" term="%22Ariane+Wohlfarth%22">Ariane Wohlfarth</searchLink><br /><searchLink fieldCode="AR" term="%22Tobias+Rautio%22">Tobias Rautio</searchLink> ) Array ( [Name] => TitleSource [Label] => Source [Group] => Src [Data] => Journal of Analytical Toxicology ) Array ( [Name] => Publisher [Label] => Publisher Information [Group] => PubInfo [Data] => Linköpings universitet, Avdelningen för läkemedelsforskning, 2019. ) Array ( [Name] => DatePubCY [Label] => Publication Year [Group] => Date [Data] => 2019 ) Array ( [Name] => Subject [Label] => Subject Terms [Group] => Su [Data] => <searchLink fieldCode="DE" term="%22Health%2C+Toxicology+and+Mutagenesis%22">Health, Toxicology and Mutagenesis</searchLink><br /><searchLink fieldCode="DE" term="%22Urinary+system%22">Urinary system</searchLink><br /><searchLink fieldCode="DE" term="%22Metabolite%22">Metabolite</searchLink><br /><searchLink fieldCode="DE" term="%22Urine%22">Urine</searchLink><br /><searchLink fieldCode="DE" term="%22Pharmacology+and+Toxicology%22">Pharmacology and Toxicology</searchLink><br /><searchLink fieldCode="DE" term="%22Toxicology%22">Toxicology</searchLink><br /><searchLink fieldCode="DE" term="%22Mass+spectrometry%22">Mass spectrometry</searchLink><br /><searchLink fieldCode="DE" term="%2201+natural+sciences%22">01 natural sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Mass+Spectrometry%22">Mass Spectrometry</searchLink><br /><searchLink fieldCode="DE" term="%22Analytical+Chemistry%22">Analytical Chemistry</searchLink><br /><searchLink fieldCode="DE" term="%22Lc+qtof+ms%22">Lc qtof ms</searchLink><br /><searchLink fieldCode="DE" term="%22Forensic+Toxicology%22">Forensic Toxicology</searchLink><br /><searchLink fieldCode="DE" term="%2203+medical+and+health+sciences%22">03 medical and health sciences</searchLink><br /><searchLink fieldCode="DE" term="%22chemistry%2Echemical%5Fcompound%22">chemistry.chemical_compound</searchLink><br /><searchLink fieldCode="DE" term="%220302+clinical+medicine%22">0302 clinical medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Enzymatic+hydrolysis%22">Enzymatic hydrolysis</searchLink><br /><searchLink fieldCode="DE" term="%22Humans%22">Humans</searchLink><br /><searchLink fieldCode="DE" term="%22Environmental+Chemistry%22">Environmental Chemistry</searchLink><br /><searchLink fieldCode="DE" term="%22030216+legal+%26+forensic+medicine%22">030216 legal & forensic medicine</searchLink><br /><searchLink fieldCode="DE" term="%22Chemical+Health+and+Safety%22">Chemical Health and Safety</searchLink><br /><searchLink fieldCode="DE" term="%22Chromatography%22">Chromatography</searchLink><br /><searchLink fieldCode="DE" term="%22Special+Issue%22">Special Issue</searchLink><br /><searchLink fieldCode="DE" term="%22Chemistry%22">Chemistry</searchLink><br /><searchLink fieldCode="DE" term="%22010401+analytical+chemistry%22">010401 analytical chemistry</searchLink><br /><searchLink fieldCode="DE" term="%22Metabolism%22">Metabolism</searchLink><br /><searchLink fieldCode="DE" term="%22Reference+Standards%22">Reference Standards</searchLink><br /><searchLink fieldCode="DE" term="%22Farmakologi+och+toxikologi%22">Farmakologi och toxikologi</searchLink><br /><searchLink fieldCode="DE" term="%22Metabolic+Detoxication%2C+Phase+II%22">Metabolic Detoxication, Phase II</searchLink><br /><searchLink fieldCode="DE" term="%220104+chemical+sciences%22">0104 chemical sciences</searchLink><br /><searchLink fieldCode="DE" term="%22Quinone%22">Quinone</searchLink><br /><searchLink fieldCode="DE" term="%22Analgesics%2C+Opioid%22">Analgesics, Opioid</searchLink><br /><searchLink fieldCode="DE" term="%22Fentanyl%22">Fentanyl</searchLink><br /><searchLink fieldCode="DE" term="%22Substance+Abuse+Detection%22">Substance Abuse Detection</searchLink><br /><searchLink fieldCode="DE" term="%22Hepatocytes%22">Hepatocytes</searchLink><br /><searchLink fieldCode="DE" term="%22Metabolic+Detoxication%2C+Phase+I%22">Metabolic Detoxication, Phase I</searchLink><br /><searchLink fieldCode="DE" term="%22Biomarkers%22">Biomarkers</searchLink><br /><searchLink fieldCode="DE" term="%22Chromatography%2C+Liquid%22">Chromatography, Liquid</searchLink> ) Array ( [Name] => Abstract [Label] => Description [Group] => Ab [Data] => Cyclopropylfentanyl is a fentanyl analog implicated in 78 deaths in Europe and over 100 deaths in the United States, but toxicological information including metabolism data about this drug is scarce. The aim of this study was to provide the exact structure of abundant and unique metabolites of cyclopropylfentanyl along with synthesis routes. In this study, metabolites were identified in 13 post-mortem urine samples using liquid chromatography quadrupole time-of-flight mass spectrometry (LC-QTOF-MS). Samples were analyzed with and without enzymatic hydrolysis, and seven potential metabolites were synthesized in-house to provide the identity of major metabolites. Cyclopropylfentanyl was detected in all samples, and the most abundant metabolite was norcyclopropylfentanyl (M1) that was detected in 12 out of 13 samples. Reference materials were synthesized (synthesis routes provided) to identify the exact structure of the major metabolites 4-hydroxyphenethyl cyclopropylfentanyl (M8), 3,4-dihydroxyphenethyl cyclopropylfentanyl (M5) and 4-hydroxy-3-methoxyphenethyl cyclopropylfentanyl (M9). These metabolites are suitable urinary markers of cyclopropylfentanyl intake as they are unique and detected in a majority of hydrolyzed urine samples. Minor metabolites included two quinone metabolites (M6 and M7), not previously reported for fentanyl analogs. Interestingly, with the exception of norcyclopropylfentanyl (M1), the metabolites appeared to be between 40% and 90% conjugated in urine. In total, 11 metabolites of cyclopropylfentanyl were identified, including most metabolites previously reported after hepatocyte incubation. ) Array ( [Name] => Format [Label] => File Description [Group] => SrcInfo [Data] => application/pdf ) Array ( [Name] => Language [Label] => Language [Group] => Lang [Data] => English ) Array ( [Name] => URL [Label] => Access URL [Group] => URL [Data] => <link linkTarget="URL" linkTerm="https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0298d28690a6bb961bbb0c4b9e34d186" linkWindow="_blank">https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0298d28690a6bb961bbb0c4b9e34d186</link><br /><link linkTarget="URL" linkTerm="http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-163109" linkWindow="_blank">http://urn.kb.se/resolve?urn=urn:nbn:se:liu:diva-163109</link> ) Array ( [Name] => Copyright [Label] => Rights [Group] => Cpyrght [Data] => OPEN ) Array ( [Name] => AN [Label] => Accession Number [Group] => ID [Data] => edsair.doi.dedup.....0298d28690a6bb961bbb0c4b9e34d186 ) |
RecordInfo |
Array
(
[BibEntity] => Array
(
[Languages] => Array
(
[0] => Array
(
[Text] => English
)
)
[Subjects] => Array
(
[0] => Array
(
[SubjectFull] => Health, Toxicology and Mutagenesis
[Type] => general
)
[1] => Array
(
[SubjectFull] => Urinary system
[Type] => general
)
[2] => Array
(
[SubjectFull] => Metabolite
[Type] => general
)
[3] => Array
(
[SubjectFull] => Urine
[Type] => general
)
[4] => Array
(
[SubjectFull] => Pharmacology and Toxicology
[Type] => general
)
[5] => Array
(
[SubjectFull] => Toxicology
[Type] => general
)
[6] => Array
(
[SubjectFull] => Mass spectrometry
[Type] => general
)
[7] => Array
(
[SubjectFull] => 01 natural sciences
[Type] => general
)
[8] => Array
(
[SubjectFull] => Mass Spectrometry
[Type] => general
)
[9] => Array
(
[SubjectFull] => Analytical Chemistry
[Type] => general
)
[10] => Array
(
[SubjectFull] => Lc qtof ms
[Type] => general
)
[11] => Array
(
[SubjectFull] => Forensic Toxicology
[Type] => general
)
[12] => Array
(
[SubjectFull] => 03 medical and health sciences
[Type] => general
)
[13] => Array
(
[SubjectFull] => chemistry.chemical_compound
[Type] => general
)
[14] => Array
(
[SubjectFull] => 0302 clinical medicine
[Type] => general
)
[15] => Array
(
[SubjectFull] => Enzymatic hydrolysis
[Type] => general
)
[16] => Array
(
[SubjectFull] => Humans
[Type] => general
)
[17] => Array
(
[SubjectFull] => Environmental Chemistry
[Type] => general
)
[18] => Array
(
[SubjectFull] => 030216 legal & forensic medicine
[Type] => general
)
[19] => Array
(
[SubjectFull] => Chemical Health and Safety
[Type] => general
)
[20] => Array
(
[SubjectFull] => Chromatography
[Type] => general
)
[21] => Array
(
[SubjectFull] => Special Issue
[Type] => general
)
[22] => Array
(
[SubjectFull] => Chemistry
[Type] => general
)
[23] => Array
(
[SubjectFull] => 010401 analytical chemistry
[Type] => general
)
[24] => Array
(
[SubjectFull] => Metabolism
[Type] => general
)
[25] => Array
(
[SubjectFull] => Reference Standards
[Type] => general
)
[26] => Array
(
[SubjectFull] => Farmakologi och toxikologi
[Type] => general
)
[27] => Array
(
[SubjectFull] => Metabolic Detoxication, Phase II
[Type] => general
)
[28] => Array
(
[SubjectFull] => 0104 chemical sciences
[Type] => general
)
[29] => Array
(
[SubjectFull] => Quinone
[Type] => general
)
[30] => Array
(
[SubjectFull] => Analgesics, Opioid
[Type] => general
)
[31] => Array
(
[SubjectFull] => Fentanyl
[Type] => general
)
[32] => Array
(
[SubjectFull] => Substance Abuse Detection
[Type] => general
)
[33] => Array
(
[SubjectFull] => Hepatocytes
[Type] => general
)
[34] => Array
(
[SubjectFull] => Metabolic Detoxication, Phase I
[Type] => general
)
[35] => Array
(
[SubjectFull] => Biomarkers
[Type] => general
)
[36] => Array
(
[SubjectFull] => Chromatography, Liquid
[Type] => general
)
)
[Titles] => Array
(
[0] => Array
(
[TitleFull] => LC-QTOF-MS Identification of Major Urinary Cyclopropylfentanyl Metabolites Using Synthesized Standards
[Type] => main
)
)
)
[BibRelationships] => Array
(
[HasContributorRelationships] => Array
(
[0] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Henrik Gréen
)
)
)
[1] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Robert Kronstrand
)
)
)
[2] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Anna Åstrand
)
)
)
[3] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Shimpei Watanabe
)
)
)
[4] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Peter Konradsson
)
)
)
[5] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Johan Dahlén
)
)
)
[6] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Svante Vikingsson
)
)
)
[7] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Xiongyu Wu
)
)
)
[8] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Jakob Wallgren
)
)
)
[9] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Ariane Wohlfarth
)
)
)
[10] => Array
(
[PersonEntity] => Array
(
[Name] => Array
(
[NameFull] => Tobias Rautio
)
)
)
)
[IsPartOfRelationships] => Array
(
[0] => Array
(
[BibEntity] => Array
(
[Dates] => Array
(
[0] => Array
(
[D] => 01
[M] => 01
[Type] => published
[Y] => 2019
)
)
[Identifiers] => Array
(
[0] => Array
(
[Type] => issn-locals
[Value] => edsair
)
[1] => Array
(
[Type] => issn-locals
[Value] => edsairFT
)
)
)
)
)
)
)
|
IllustrationInfo |